Literature DB >> 30201423

Movement disorders in autoimmune encephalitis and paraneoplastic neurological syndromes.

J Honnorat1, B Joubert2.   

Abstract

Movement disorders are extremely common and diverse in autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS). They can sometimes represent the main neurological disorder of a given patient, or just be part of a larger neurological syndrome. Early diagnosis of AE or PNS is essential, as the associated abnormal movements can be effectively treated with immunomodulators. Nevertheless, the diagnosis is often delayed because of the large number of differential diagnoses (infections, metabolic disorders, genetic and degenerative diseases) and because the semiology of abnormal movements arising during AE and PNS is often not well known. However, there are highly specific clinical features, depending on the associated autoantibodies, age and gender of the patient, and associated cancers. Such features are likely to rely on specific mechanisms, the knowledge of which could lead to new therapeutic proposals. Also, the growing body of work on AE and PNS provides a better understanding of the links between immunity and neuronal degeneration, and immunity and genetic specificities. Thus, the purpose of this article is to present the current knowledge and different subtypes of movement disorders associated with AE and PNS, as well as the mechanisms that can lead to neuronal dysfunction.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Abnormal movement; Auto-anticorps; Autoantibodies; Autoimmune encephalitis; Chorea; Chorée; Dyskinésie oro-faciale; Dystonia; Dystonie; Encéphalite auto-immune; Mouvements anormaux; Neuroimmunologie; Neuroimmunology; Orofacial dyskinesia; Paraneoplastic neurological syndrome; Syndrome neurologique paranéoplasique

Mesh:

Year:  2018        PMID: 30201423     DOI: 10.1016/j.neurol.2018.07.006

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  3 in total

1.  Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease.

Authors:  Pauline Shambrook; Adèle Hesters; Clémence Marois; Daniel Zemba; Jérôme Servan; Bertrand Gaymard; Fernando Pico; Cécile Delorme; Catherine Lubetzki; Isabelle Arnulf; Dimitri Psimaras; Jérôme Honnorat; Ana Gales; Aurélie Méneret
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-13

Review 2.  Treatable Hyperkinetic Movement Disorders Not to Be Missed.

Authors:  Aurélie Méneret; Béatrice Garcin; Solène Frismand; Annie Lannuzel; Louise-Laure Mariani; Emmanuel Roze
Journal:  Front Neurol       Date:  2021-12-01       Impact factor: 4.003

3.  Autoimmune Encephalitis in Tunisia: Report of a Pediatric Cohort.

Authors:  Bissene Douma; Thouraya Ben Younes; Hanene Benrhouma; Zouhour Miladi; Imen Zamali; Aida Rouissi; Hedia Klaa; Ichraf Kraoua; Melika Ben Ahmed; Ilhem Ben Youssef Turki
Journal:  J Immunol Res       Date:  2021-05-10       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.